Price
$2.65
Decreased by -1.12%
Dollar volume (20D)
27.95 M
ADR%
23.17
Shares float
3.33 M
Shares short
1.10 K [0.03%]
Shares outstanding
3.53 M
Market cap
10.11 M
Beta
2.25
Price/earnings
N/A
20D range
0.89 7.00
50D range
0.89 7.00
200D range
0.89 21.95

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.

It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-101, an IL13Ra2 CAR T cell program for glioblastoma; and MB-108 for the treatment of herpes simplex virus-1 oncolytic virus C134.

The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 13, 25 -0.95
Decreased by -105.79%
-
Mar 10, 25 3.63
Increased by +521.81%
-8.00
Increased by +145.35%
Nov 12, 24 -0.04
Increased by +97.14%
-0.13
Increased by +69.23%
Aug 13, 24 -0.35
Increased by +82.27%
-0.14
Decreased by -153.29%
May 15, 24 -0.46
Increased by +77.61%
-0.87
Increased by +46.98%
Mar 11, 24 -0.86
Increased by +68.15%
-1.33
Increased by +35.34%
Nov 14, 23 -1.40
Decreased by -677.78%
-1.27
Decreased by -10.24%
Aug 14, 23 -2.00
Decreased by -952.63%
-1.81
Decreased by -10.50%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 0.00
Decreased by N/A%
-153.00 K
Increased by +97.05%
Decreased by N/A%
Decreased by N/A%
Dec 31, 24 0.00
Decreased by -100.00%
-952.00 K
Increased by +88.95%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-1.41 M
Increased by +85.98%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-8.20 M
Increased by +49.50%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-5.19 M
Increased by +71.54%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 2.88 M
Increased by +N/A%
-8.62 M
Increased by +58.68%
Decreased by -298.96%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-10.06 M
Increased by +47.05%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-16.23 M
Increased by +15.00%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY